Related Experiment Videos
Lysostaphin-coated catheters eradicate Staphylococccus aureus challenge and block surface colonization
Anjali Shah1, James Mond, Scott Walsh
1Biosynexus, Inc., 9119 Gaither Road, Gaithersburg, MD 20877, USA.
Antimicrobial Agents and Chemotherapy
|June 25, 2004
Summary
Lysostaphin, an enzyme effective against Staphylococcus aureus, was used to coat catheters. This coating prevented bacterial colonization for at least four days, suggesting a method to prevent infections.
Area of Science:
- Microbiology
- Biochemistry
- Infectious Diseases
Background:
- Staphylococcus aureus is a primary cause of catheter-related infections.
- Lysostaphin is an endopeptidase with bactericidal activity against S. aureus.
Purpose of the Study:
- To evaluate the efficacy of lysostaphin-coated catheters in preventing S. aureus colonization.
- To determine the duration of lysostaphin activity on catheter surfaces.
Main Methods:
- Coating medical catheters with lysostaphin.
- Challenging coated catheters with various strains of S. aureus.
- Assessing bacterial colonization over time.
Main Results:
- Lysostaphin-coated catheters demonstrated prevention of S. aureus colonization.
- The anti-staphylococcal activity of the coating persisted for a minimum of 4 days.
- Effectiveness was observed against multiple strains of S. aureus.
Conclusions:
- Lysostaphin coating is a viable strategy to prevent S. aureus catheter colonization.
- Prophylactic application of lysostaphin on catheters shows potential in reducing staphylococcal infections.
- This approach offers a promising method for enhancing catheter safety in clinical settings.